TrianglePUBLICATIONS · 19424940
Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Horm Metab Res
- Publication date
- 2009 Sep
- First author
- Druce MR
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Druce MR
- type
- Author
- name
- Kaltsas GA
- type
- Author
- name
- Fraenkel M
- type
- Author
- name
- Gross DJ
- type
- Author
- name
- Grossman AB
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Druce MR
- type
- Author
- name
- Kaltsas GA
- type
- Author
- name
- Fraenkel M
- type
- Author
- name
- Gross DJ
- type
- Author
- name
- Grossman AB
- type
- Author
- bibliography ids
- nci-bib-beb0ab041d56c03ae12ba369
- book metadata
- content sha256
- 4fa29028d82ed976e04716e515a7fe0d1cc41d9d24c5bce93b99b0beee7e1bae
- document type
- citation
- dois
- 10.1055/s-0029-1220687
- electronic publication date
- display
- 2009 May 7
- precision
- day
- year
- 2009
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19424940
- immutable id
- pubmed:19424940@4fa29028d82ed976e04716e515a7fe0d1cc41d9d24c5bce93b99b0beee7e1bae
- journal
- abbreviation
- Horm Metab Res
- issn electronic
- 1439-4286
- issn print
- 0018-5043
- issue
- 9
- name
- Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
- nlm unique id
- 0177722
- pages
- 697-702
- volume
- 41
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19424940
- provenance
- batch id
- 4f803f1a8e7b4f56d2f1
- provider
- NCBI PubMed ESummary
- record sha256
- 4dd19db51b05c8dd78739953af1084cb4692ef9cd59f3aac9d746fe3f20bc0a0
- response sha256
- fddd7745d591ed24e15d20ce21f0a6c14874b8cee29153ff89c9892037c40127
- retrieved at
- 2026-09-09T23:46:26.391289+00:00
- publication date
- display
- 2009 Sep
- precision
- month
- year
- 2009
- publication types
- Case Reports
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
Preserved source evidence · Not medical advice